Black Diamond Therapeutics Inc
XNAS:BDTX 4:00:00 PM EDT
| Market Cap (Intraday) | 120.66M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.13 |
| 50-Day MA | $1.96 |
| 200-Day MA | $2.39 |
Black Diamond Therapeutics Inc Stock, XNAS:BDTX
One Main Street, 14th floor, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.252.0848
Number of Employees: 24
Description
Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.